Serotonin
Transporter
●
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a
genetic susceptibility mechanism for depression.
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana
BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR.
Nat Neurosci. 2005 May 8.
● Association
of serotonin transporter gene polymorphism with obstructive sleep apnea
syndrome.
Ylmaz M, Bayazit YA, Ciftci TU, Erdal ME, Urhan M, Kokturk O, Kemaloglu YK, Inal
E.
Laryngoscope. 2005 May;115(5):832-6.
● The
interaction of stressful life events and a serotonin transporter polymorphism in
the prediction of episodes of major depression: a replication.
Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B.
Arch Gen Psychiatry. 2005 May;62(5):529-35.
● Serotonin
transporter: Evolution and impact of polymorphic transcriptional regulation.
Soeby K, Larsen SA, Olsen L, Rasmussen HB, Werge T.
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 27.
● Association
between 5-HTTLPR genotypes and persisting patterns of anxiety and alcohol use:
results from a 10-year longitudinal study of adolescent mental health.
Olsson CA, Byrnes GB, Lotfi-Miri M, Collins V, Williamson R, Patton C, Anney RJ.
Mol Psychiatry. 2005 Apr 26.
● Role of the
serotonin transporter gene and family function in adolescent alcohol
consumption.
Nilsson KW, Sjoberg RL, Damberg M, Alm PO, Ohrvik J, Leppert J, Lindstrom L,
Oreland L.
Alcohol Clin Exp Res. 2005
Apr;29(4):564-70.
● Evaluating
Associations between 5-HTTLPR Polymorphism and Alzheimer's Disease for Korean
Patients.
Ha TM, Cho DM, Park SW, Joo MJ, Lee BJ, Kong BG, Kim JM, Yoon JS, Kim YH.
Dement Geriatr Cogn Disord. 2005 Apr 12;20(1):31-34.
● Controlled
clinical comparison of paroxetine and fluvoxamine considering the serotonin
transporter promoter polymorphism.
Kato M, Ikenaga Y, Wakeno M, Okugawa G, Nobuhara K, Fukuda T, Fukuda K, Azuma J,
Kinoshita T.
Int Clin Psychopharmacol. 2005 May;20(3):151-6.
● Association
of the serotonin transporter promoter polymorphism with smoking behavior among
adolescents.
Gerra G, Garofano L, Zaimovic A, Moi G, Branchi B, Bussandri M,
Brambilla F, Donnini C.
Am J Med Genet B Neuropsychiatr Genet.
2005 May 5;135(1):73-8.
● Association
of the serotonin transporter gene polymorphism with Korean male alcoholics.
Kweon YS, Lee HK, Lee CT, Lee KU, Pae CU.
J Psychiatr Res. 2005
Jul;39(4):371-376.
● Male
Reproductive Timing in Rhesus Macaques Is Influenced by the 5HTTLPR Promoter
Polymorphism of the Serotonin Transporter Gene.
Krawczak M, Trefilov A, Berard J, Bercovitch F, Kessler M, Sauermann U, Croucher
P, Nurnberg P, Widdig A, Schmidtke J.
Biol Reprod. 2005 May;72(5):1109-13.
● The
serotonin transporter gene as a QTL for ADHD.
Curran S, Purcell S, Craig I, Asherson P, Sham P.
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134(1):42-7.
Dopamine
Transporter
● Increased
Dopamine Transporter Availability Associated with the 9-Repeat Allele of the
SLC6A3 Gene.
van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin
RM, Innis RB, Gelernter J.
J Nucl Med. 2005 May;46(5):745-51.
●
Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.
Kim JY, Jung IK, Han C, Cho SH, Kim L, Kim SH, Lee BH, Lee HJ, Kim YK.
Psychiatry Clin Neurosci. 2005 Apr;59(2):183-8.
● Association
analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar
disorder.
Keikhaee MR, Fadai F, Sargolzaee MR, Javanbakht A, Najmabadi H, Ohadi M.
Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135(1):47-9.
Other
Transporters
● Frontal and
limbic metabolic differences in subjects selected according to genetic variation
of the SLC6A4 gene polymorphism.
Graff-Guerrero A, De la Fuente-Sandoval C, Camarena B, Gomez-Martin D, Apiquian
R, Fresan A, Aguilar A, Mendez-Nunez JC, Escalona-Huerta C, Drucker-Colin R,
Nicolini H.
Neuroimage. 2005 May 1;25(4):1197-204.
● Single
nucleotide polymorphisms modify the transporter activity of ABCG2.
Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B,
Bates SE.
Cancer Chemother Pharmacol. 2005 Apr 19.
● Lithium
response and -116C/G polymorphism of XBP1 in Japanese patients with bipolar
disorder.
Kakiuchi C, Kato T.
Int J Neuropsychopharmacol. 2005 Apr 19;:1-2.
● Vitamin
D-binding protein gene polymorphism association with IA-2 autoantibodies in type
1 diabetes.
Ongagna JC, Pinget M, Belcourt A.
Clin Biochem. 2005 May;38(5):415-419.
● ATP-binding
cassette transporter G8 M429V polymorphism as a novel genetic marker of higher
cholesterol absorption in hypercholesterolemic Japanese subjects.
Miwa K, Inazu A, Kobayashi J, Higashikata T, Nohara A, Kawashiri M, Katsuda S,
Takata M, Koizumi J, Mabuchi H.
Clin Sci (Lond). 2005 Apr 7.
● Genetic
predictors of the maximum doses patients receive during clinical use of the
anti-epileptic drugs carbamazepine and phenytoin.
Tate SK, Depondt C, Sisodiya SM, Cavalleri GL, Schorge S, Soranzo N, Thom M, Sen
A, Shorvon SD, Sander JW, Wood NW, Goldstein DB.
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5507-12.
● Discovery of
the ergothioneine transporter.
Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N,
Rubbert A, Schomig E.
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5256-61.
● Association
of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population.
Daimon M, Kido T, Baba M, Oizumi T, Jimbu Y, Kameda W, Yamaguchi H, Ohnuma H,
Tominaga M, Muramatsu M, Kato T.
Biochem Biophys Res Commun. 2005 Apr 1;329(1):205-10.
● DNA pooling
analysis of 21 norepinephrine transporter gene SNPs with attention deficit
hyperactivity disorder: no evidence for association.
Xu X, Knight J, Brookes K, Mill J, Sham P, Craig I, Taylor E, Asherson P.
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134(1):115-8.
● Support for
association between ADHD and two candidate genes: NET1 and DRD1.
Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen
LS, Sharp WS, Inoff-Germain G, Wavrant-De Vrieze F, Arcos-Burgos M, Straub RE,
Hardy JA, Castellanos FX, Rapoport JL.
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134(1):67-72.
